Extendicare (TSE:EXE) Reaches New 12-Month High – Should You Buy?

Extendicare Inc. (TSE:EXE) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as C$27.83 and last traded at C$27.83, with a volume of 67245 shares trading hands. The stock had previously closed at C$26.78.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Cormark upped their price target on shares of Extendicare from C$25.00 to C$30.00 in a report on Wednesday, December 3rd. Canaccord Genuity Group raised their price objective on shares of Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. National Bank Financial upped their target price on shares of Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Royal Bank Of Canada upgraded Extendicare from a “hold” rating to a “moderate buy” rating and increased their target price for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. Finally, BMO Capital Markets lifted their price target on Extendicare from C$24.00 to C$30.00 in a research note on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Extendicare has a consensus rating of “Buy” and an average price target of C$25.36.

Extendicare Stock Up 2.4%

The stock’s fifty day moving average price is C$25.11 and its 200-day moving average price is C$20.87. The company has a quick ratio of 0.98, a current ratio of 1.37 and a debt-to-equity ratio of 91.85. The company has a market capitalization of C$2.59 billion, a price-to-earnings ratio of 24.65 and a beta of 1.30.

Extendicare (TSE:EXE) last announced its earnings results on Thursday, February 26th. The company reported C$0.29 EPS for the quarter. The business had revenue of C$462.03 million during the quarter. Extendicare had a net margin of 5.82% and a return on equity of 47.65%. On average, sell-side analysts predict that Extendicare Inc. will post 0.6134729 earnings per share for the current fiscal year.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.